Кальцинированный аортальный стеноз в клинике внутренних болезней-взаимосвязь с системным обменом кальция и костным метаболизмом
Диссертация
Впервые на большом материале проведено комплексное изучение нарушений костного обмена при кальцинированном аортальном стенозе, включавшее определение уровней общего кальция, щелочной фосфатазы, витамина Д, паратгормона, маркеров костного ремоделирования в сочетании с двухэнергетической абсорбциометрией, позволившее установить следующие закономерности. Показана высокая распространенность (71… Читать ещё >
Список литературы
- Аврунин A.C., Корнилов Н. В., Иоффе И. Д., Емельянов В. Г. Параметры метаболизма минерального матрикса костной ткани //Остеопороз и остеопатии. 2000. — № 4. — С. 2 — 4.
- Алехин М.Н., Седов В. П. Допплер-эхокардиография. //М. 1997. — С. 5057.
- Андропова A.B. Прогнозирование формирования и прогрессирования дегенеративного аортального стеноза по факторам риска. //Дис.к.м.н. — М.-2005.-С. 79−89.
- Андропова О.В. Атеросклероз, остеопороз и дегенеративный аортальный стеноз: клинические параллели. //Клиницист. — 2006. — № 1. — С. 5−7.
- Аникин С.Г., Беневоленская Л. И. Остеопороз и кардиоваскулярные заболевания. Научно-практическая ревматология. — 2006. № 5. — С. 3945.
- Белосельский H.H. Рентгеновская морфометрия позвоночника в диагностике остеопороза. //Остеопороз и остеопатии. 2000. — № 1. — С. 23−26.
- Беневоленская Л.И. Остеопороз актуальная проблема медицины.
- Остеопороз и остеопатии. 1998. — № 1. — С. 4—7.
- Беневоленская Л.И. Общие принципы профилактики и леченияостеопороза. //Консилиум. 2000. — № 2. — С. 240−244.
- Внутренние болезни. Руководство: в 2 т. Под ред. А. И. Мартынова, H.A. Мухина, B.C. Моисеева, A.C. Галявича- М.: ГЭОТАР-МЕД- 2001. Т. 1. -С. 127−131.
- Динамическая электрокардиография в оценке ишемии миокарда. Метод, реком. под ред. проф. Чирейкина JI.B. //С-Пб.: ИНКАРТ. 1994. -41 с.
- Долгов В.В., Ермакова И. П. Лабораторная диагностика обмена костной ткани. Основные компоненты костной ткани. //Остеопороз и остеопения. —2000.-№ 4.-С. 29−39.
- Дупляков Д.В., Емельяненко В. М. Возможности стресс-эхокардиографии в диагностике патологии аортального клапана. Ч. 1. //Кардиология. 2002. — № 8. — С. 87−91.
- Егоров И.В. Сенильный кальцинированный стеноз устья аорты: клинико-инструментальная характеристика. //Автореф. дис.к.м.н. — М.2001.-С. 1−3.
- Ершова О.Б., Семенова О. В., Дегтярев A.A. Результаты проспективного изучения исходов переломов проксимального отдела бедра у лиц пожилого возраста. //Остеопороз и остеопатии. 2000. — № 1. — С. 9−10.
- Иртюга О.Б., Раскина Т. А. Состояние минеральной плотности кости у больных, перенесших инфаркт миокарда. //Научно-практическая ревматологияю 2006. — № 5. — С. 91−95.
- Камкин А.Г., Ярыгин Н. В., Киселева И. С. Механоэлектрическая обратная связь в сердце. //М.: Натюрморт. 2003. — С. 25−30.
- Клейменова Е.Б. Клинико-эхокардиографическая и гемодинамическая характеристика аортального стеноза. //Автореф. дис.к.м.н. М. — 1992. — С. 1−3.
- Лекции по кардиологии: в 3-х т., под ред. Л. А. Бокерия, Е.З.
- Голоуховой. М.: НЦССХ им. А. Н. Бакулева РАМН. — 2001. — Т. 2. — С. 262 275.
- Маколкин В.И., Овчаренко С. И. Внутренние болезни: Учебник. 4-е изд. /Мл Медицина — 1999. — С. 155 — 160.
- Международная статистическая классификация болезней и проблем, связанных со здоровьем- 10-й пересмотр. //М.: Медицина. — 2003. — С. 496.
- Михайлов Е.Е., Беневоленская Л. И. Эпидемиология остеопороза и переломов. Руклвлдство по остеопорозу.7/М. БИНОМ. 2003. — С. 10−53.
- Назаренко Г. И., Кишкун A.A. Клиническая оценка результатов лабораторных исследований. М.: Медицина. 2000. — 544с.
- Насонов Е.Л. Остеопороз и заболевания сердечно-сосудистой системы. //Кардиология. 2002. — № 3. — С. 80 — 82.
- Насонов Е.Л., Попкова Т. В. Кардиоваскулярные проблемы в ревматологии. //Научно-практическая ревматология. 2004. — № 4. — С. 4 — 8.
- Национальные рекомендации по диагностике и лечению ХСН (утверждены съездом кардиологов РФ • в октябре 2003 г.). //Сердечная недостаточность. 2003. — Т. 4. — № 6. — С. 276 — 297.
- Нестеров B.C. Клиника болезней сердца и сосудов. 3-е изд., испр. и доп. // Киев «Здоров'я». — 1974. — С. 174−176.
- Новиков В.К., Павлыш Е. Ф., Дамадж Абдулкарим, Бондаренко Б.Б. Отдаленные результаты аортального протезирования. //Вестник аритмологии. 2001. — № 21. — С. 56−58.
- Оценка риска переломов е ее применение для скрининга постменопаузального остеопороза: Докл. Рабочей группы ВОЗ. //Женева. Всемирная организация здравоохранения. 1994. — 184 с.
- Пожилые люди в Российской Федерации: положение, проблемы, перспективы: Нац. докл. II Всемирная ассамблея по проблемам старения, Мадрид, 2002 (апрель). //М.: Права человека. 2002.
- Полубенцева Е.И. Воспалительные заболевания сердца: лекции по кардиоревматологии в слайдах и табл.: Учебное пособие. //М. 2002. — 94 с.
- Программа развития ООН «Возраст мудрости возраст созидания». // М.- 1999.-96 с.
- Рашид М.А. Кальцинированный аортальный стеноз дегенеративного генеза клинико-инструментальные сопоставления с показателями костного метаболизма. //Дис. .к.м.н. — М — 2005. — С. 83−94.
- Реброва О.Ю. Статистический анализ медицинских данных. //М.: Медиасофт. 2002. — 312 с.
- Риггс Б.Л., Мелтон Л. Д. Остеопороз. IIМ.: Бином- СПб.: Нев. Диалект. -2000. 560 с.
- Руководство по остеопорозу. Под ред. Л. И. Беневоленской. //М.: БИНОМ. Лаборатория знаний.- 2003.- с. 320−347.
- Рябыкина Г. В. Диагностика ишемии миокарда методом холтеровского мониторирования ЭКГ. //Вестник аритмологии. 2002. — № 26.-С. 5−9.
- Терапевтический справочник Вашингтонского университета. 2-ое рус. изд. Под ред. Ч. Кэри, X. Ли и К. Велтье. пер. с анг. //Практика -2000. С. 605 — 609.
- Терновой С.К., Синицын В. Е. Спиральная компьютерная и электроннолучевая ангиография. //М.:Видар. 1998. — С. 115−140.
- Торопцова Н.В., Никитинская О. А., Демин Н. В., Беневоленская Л. И. профилактика постменопаузального остеопороза: результаты трехгодичного наблюдения. //Научно-практическая ревматология. 2006. — № 5. — С. 25−32.
- Шиллер Н., Осипов М. А. Клиническая эхокардиография. //М.: Практика. 1993. — С. 290−295.
- Absil В., Dagenais F., Mathieu Р. et al. Does moderate mitral regurgitation impact early or midterm clinical outcome in patients undergoing isolated aortic valve replacement for aortic stenosis. //Europ. J. Cardiothorac. Surg. 2003. -№ 3. — P. 217.
- ACC/AHA guidelines for the management of patients with valvular heart disease. //J. Am. Coll. Cardiol. 1998.-№ 32. — P. 1486−1588.
- ACC/AHA 2006 Practice Guidelines for the management of patients with valvular heart disease. //JACC. 2006. — 48 (3). — P. 598−675.
- Adler Y., Koren A., Fink N. et al. Association between mitral annulus calcification and carotid atherosclerotic disease. //Stroke. 1998. — № 29. — P. 1833 — 1837.
- Agmon Y. et all. Aortic valve sclerosis and aortic aterosclerosis: different manifestations of the same disease? //J.A.C.C. 2001. — № 38. — P. 827−834.
- Agozzino L, Ferraraccio F, Esposito S et al. Medial degeneration does not involve uniformly the whole ascending aorta: morphological, biochemical and clinical correlation. //Eur. J. Cardio-thorac. Surg. 2002. — № 4. — P.675−682.
- Alyono D., Anderson R.W., Parrish D.G. et al. Alterations of myocardial blood flow associated with experimental canine left ventricular hypertrophy secondary to valvular aortic stenosis. //Circ. Res. 1988. — № 58. — P. 47−57.
- Amato M.C., Moffa P J., Verner K.E., Ramires J.A. Treatment decision in asymptomatic aortic stenosis: role of exercise testing. //Heart. 2001. — № 86. -P. 381−386.
- Amin S., Yuquing Z., Clark T. et al. Association of hypogonadism and oestradiol levels with bone mineral density in elderly men from the Framingham Study. //Ann. Intern. Med. 2000. — № 133. — P. 951 — 963.
- Anderson R.H., Devine W.A., Ho S.Y. et al. The myth of the aortic annulus: the anatomy of the subaortic outflow tract. //Ann. Thorac. Surg. — 1991. -№ 51. -P. 640−664.
- Anderson P.G., Bishop S.P., Digerness S.B. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats. //Circ. Res. 1989. — № 64. — P. 1127−1136.
- Anderson F.H., Francis R.M., Selby P.L. et al. Sex hormones and osteoporosis in men. //Calcif. Tissue. Int. 1998. -№ 62. — P. 185 — 188.
- Anderson H.C. Molecular biology of matrix vesicles //Clin. Orthop. 1995. -№ 314.-P. 266−280.
- Anderson R.D., Pepine C.J. Gender Differences in the Treatment for Acute Myocardial Infarction: Bias or Biology? //Circulation. -2007. № 115(7). — P. 823 — 826.
- Antonini- Canterin F., Faggiano P., Z. anuttini D. Is aortic valve resistance more clinically meaningful than valve area in aortic stenosis? //Heart. 1999. -№ 82.-P. 9−10.
- Antonini- Canterin F., Pavan D., Burelli C. et al. Validation of the ejection fraction-velocity ratio: a new simplified «function-corrected» index forassessing aortic stenosis severity. // Amer. J. Cardiol. 2000. — № 86. — P. 427 433.
- Antonini-Canterin F., Huang G. et al. Symptomatic aortic stenosis. Does systemic hypertension play an additional role? //Hypertension. 2003. — № 41. -P. 1268−1272.
- Antonini-Canterin F., Popescu B.A., Huang G. et al. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment. //Ital. Heart J. 2005. — № 6(2). — P. 119−124.
- Antos C.L., McKinsey T.A., Frey N. et al. Activated glycogen synthase-3 suppresses cardiac hypertrophy in vivo. //Proc. Natl. Acad. Sci. USA. 2002. -№ 99. — P. 907−909.
- Archer S.I., Mike D.K., Hetland M.B. et al. Usefulness of mean aortic valve gradient and left ventricular diastolic filling pattern for distinguishing the symptomatic from the asymptomatic patients. //Am. J. Cardiol. 1994. — № 73. -P. 275−281.
- Arenillas J., Candell-Riera J., Romero-Farina G. et al. Silent Myocardial Ischemia in Patients With Symptomatic Intracranial Atherosclerosis: Associated Factors. //Stroke. -2005. -№ 36. P. 1201−1206.
- Aronow W.S., Ann C., Kronzon I., Goldman M.E. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. //Am. J. Cardiol. 2001. — № 88. — P. 693 — 695.
- ACC/AHA guidelines for the management of patients with valvular heartdisease: a report of the American College of Cardiology/American Heart
- Association Task Force on Practice Guidelines (Committee on Management of
- Patients with Valvular Heart Disease). //J. Am. Coll. Cardiol. 1998. — № 32. — P.1486−1588.
- Arthur W., Kaye G. The pathophysiology of common causes of syncope. //Postgrad. Med. J. 2000. — № 76. — P. 750−753.
- Atar S., Jeon DS., Luo H., Siegel RJ. Mitral annular calcification: a marker of severe coronary artery disease in patients under 65 years old. //Heart. — 2003. -№ 89.-P. 161 164.
- Attenhofer C.H., Turina J., Mayer K. et al. Echocardiography in the evolution of systolic murmurs of unknown cause. //Am. J. Med. 2000. — № 108.-P. 614−620.
- Aubin J.E., Liu F., Malaval L. et al. Osteoblast and chondroblast differentiation. //Bone. 1995. -№ 17. — P. 77S-83S.
- Aurigemma G.P., Gaasch W.H. Low flow low gradient aortic stenosis. //J. Am. Coll. Cardiol. — 2004. — № 9(44). — P. 1856−1858.
- Aurigemma G.P., Silver K.H., Priest M.A. et al. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive LVH. //J. Am. Coll. Cardiol. 1995. № 26. — P. 195−202.
- Bagger Y.Z., Rasmussen H.B., Alexandersen P. et al. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? //Osteoporos. Int. 2007. — № 18(4). — P. 505 512.
- Bahler R.C., Desser D.R., Finkelhor R.S. et al. Factors leading to progression of valvular aortic stenosis. //Amer. J. Cardiol. 2001. — № 88. — P. 693−695.
- Barletta G., De Feo M.L., Del Bene R. et al. Cadiovascular effects of parathyroid hormone. //J. Clin. Endocrinol. Metab. 2000. — № 85. — P. 18 151 821.
- Barreiro C.J., Patel N.D., Fitton T.P. et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly. //Circulation. 2005. — № 112.-P. 443−447.
- Bauwens F.R., Duprez D.A., De Buyzere ML et al. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension. //Am. J. Cardiol. 1991. — 68. — P. 925−929.
- Bellamy M.F., Pellikka P.A., Klarich K.W. et al. Association of cholesterol levels, statins treatment, and progression of aortic stenosis in the community. //J. Am. Coll. Cardiol. 2002. — № 40(10). — P. 1723−1730.
- Benditt D.G. Neuronally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. //P.A.C.E. 1997. -№ 20. -P. 573.
- Benjamin E.J., Plehn J.F., D’Aagostino R.B. et al. Mitral annular calcification and the risk of stroke in an elderly cohort. //N. Engl. J. Med. -1992. № 327. — P. 374−379.
- Bermejo J., Odreman R., Feijoo J. et al. Clinical efficacy of Doppler -echocardiographic indices of aortic valve stenosis: a comparative test-based analysis of outcome// J. Amer. Coll. Cardiol. 2003. — № 41. — P. 142−151.
- Biagini A. et al. An acute transient myocardial ischemia. //Am. J. Coll. Cardiol. 1983. — № 26. — P. 105−113.
- Bikkina M., Larson M., Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subject with LVH. //Am. J. Coll. Cardiol. 1993. — № 22. -P. 1111−1116.
- Bikle D.D. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. //Endocr. Rev. 1992. — № 13. — P. 765−784.
- Bishop V.S., Hayworth G.R. Hormonal control of cardiovascular reflexes. //In Reflex control of the circulation. Boca Raton: CRC Press. — 1991. — P. 253 -271.
- Black D., Cooper C. Epidemiology of fractures and assessment of fracture risk. //Clin. Lab. Med. 2000. — № 20. — P. 439 — 453.
- Bogin E., Massry S., Harary I. Effect of parathyroid hormone on rat heart cells. //J. Clin. Invest. 1981. -№ 67. — P. 1215−27.
- Boon D., van Goudoever J., Piek J., van Montfrans G.A. ST segment depression criteria and the prevalence of silent cardiac ischemia in hypertensives. //Hypertension. 2003. — № 41. — P. 476−481.
- Boon D, Piek JJ, van Montfrans GA. Silent ischaemia and hypertension. //J. Hypertens. 2000. — № 18. — P. 1355−1364.
- Boon A., Cheriex E., Lodder J. et al. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. //Heart. 1997. — № 78. — 472−474.
- Braunwald E. On the natural history of severe aortic stenosis editorial. //J. Am. Coll. Cardiol. 1990. -№ 15. — P. 1018−1020.
- Brener S.J., Duffy C.I., Thomas J.D. et al. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. //J. Am. Coll. Cardiol. 1995.-№ 25.-P. 305−310.
- Breisch E.A., Houser S.R., Carey R.A. et al. Myocardial blood flow and capillary density in chronic pressure overload of the feline left ventricle. //Cardiovasc. Res. 1989. -№ 14. — P. 469−475.
- Briand M., Lemieux I., Dumesnil J. G. et al. Metabolic Syndrome Negatively Influences Disease Progression and Prognosis in Aortic Stenosis. // J. Am. Coll. Cardiol. 2006. — № 47(11). — P. 2229 — 2236.
- Brutsaert D.L., Sys S.U. Relaxation and diastole of the heart. //Physiol. Rev.-1989.-№ 69.-P. 1228−1315.
- Browner W.S., Lui L.Y., Cummings S.R. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. //J. Clin. Endocrinol. Metab. 2001. — № 86. — P. 631−637.
- Browner W.S., Seeley D.F., Vogt T.M., Cummings S.R. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group //Lancet. 1991. — № 338. — P. 355 358.
- Bunting C. The formation of the bone with cellular (red) marrow in a sclerotic aorta. //J. Exp. Med. 1906. — № 8. — P. 365 — 376.
- Canadian Consensus conference on osteoporosis, 2006 update. SOGC clinical practice guideline. //JOGC. 2006. — № 2 (fevrier). — P. S95-S112.
- Carabello B. Evolution of the study of left ventricular function. //Circulation. -2002. -№ 105. P. 2701−2703.
- Carabello B. Aortic stenosis. //N. Engl. J. Med. 2002. — № 346. — № 9. -P. 677−682.
- Carabello B.A. The pathophysiology of mitral regurgitation. //J. Heart Valve Dis. 2000. — № 9. — P. 600−608.
- Carabello B.A. Is it too late to operate on the patient with valvular heart, disease. //J. Am. Coll. Cardiol. 2004. — № 2(44). — P. 376−383.
- Carpentier A, Guerinon J, Deloche A, et al. Pathology of the mitral valve. In: Kalmanson D, ed. The mitral valve: a pluridisciplinary approach. Acton, Massachusetts: Publishing Sciences Group, Inc. 1976. — P. 65−88.
- Cashman KD. Vitamin D in childhood and adolescence. //Postgrad. Med. J. 2007. — № 83(978). — P. 230−235.
- Chan K.L. Is aortic stenosis a preventable disease? //JACC. 2003. — Vol. 42.-№ 4.-P. 593−599.
- Chizner M.A., Pearle D.L., de Leon A.C. The natural history of aortic valve stenosis in adults. //Am. Heart J. 1980. — № 99. — P. 419−424.
- Chiu K.Y., Pun W.K., Luk K.D., Chow S.P. A prospective study on hip fractures in patients with previous cerebrovascular accidents. //Injury. 1992. -№ 23. -P. 297−299.
- Chalmers J., Conacher W.D., Gardner D.L., Scott P.J. Osteomalacia, a common disease in elderly women. //J. Bone. Joint Surg. — 1967. — № 49B. — P. 403−423.
- Chan K.L. Is aortic stenosis a preventable disease? //JACC. 2003. — Vol. 42.-№ 4.-P. 593−599.
- Chan K.L., Ghani M., Woodend K., Burwash I. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. //Am. J. Cardiol. 2001. — № 88. — P. 690−693.
- Chandra H.R. et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. //J.A.C.C. 2004. — № 43. — P. 169 175.
- Chapuy M.C., Preziosi P., Maamer M. et al. Prevalence of vitamin D insufficiency in an adult normal population. //Osteoporos. Int. 1997. — № 7. -P. 439−443.
- Chel V.G., Ooms M.E., Popp-Snijders C. et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in-the elderly. //J. Bone Miner. Res. 1998. — № 13. — P. 1238−1242.
- Christiansen P., Steiniche T., Brixen K. et al. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients. //Bone. 1999. — № 25. — P. 589−595.
- Christakis G.T., Joyner C.D., Morgan C.D. et al. Left ventricular mass regression early after aortic valve replacement. //Ann. Thorac. Surg. 1996. -№ 62.-P. 1084−1089.
- Chui M.C., Newby D.E., Panarelli M. et al. Association between calcific aortic stenosis and hypercholesterolemia: is there need for a randomized controlled trial of cholesterol-lowering therapy? //Clin. Cardiol. — 2002. № 24.-P. 52−55.
- Clark-Greuel J.N., Connolly J.M., Sorichillo E. et al. Transforming growth factor-beta 1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. //Ann. Thorac. Surg. 2007. — № 83(3). — P. 946−953.
- Collins D., Jasani C., Fogelman I., Swaminathan R. Vitamin D and bone minimal density. //Osteoporos. Int. 1998. — № 8. — P. 110−114.
- Compston J. Treatments for osteoporosis looking beyond the HORIZON. //N. Engl. J. Med. — 2007. -№ 356(18). — P. 1878−1880.
- Compston J.E., Cooper C., Kanis J.A. Bone densitometry in clinical practice.//B.M.J. 1995.-№ 310.-P. 1507−1510.
- Connolly H.M., Oh J.K., Shaff H.V., Roger V.L. et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular disfunction: result of aortic valve replacement in 52 patient. //Circulation. 2000. — № 101. -P. 1940−1946.
- Consensus Development Conference. Prophylaxis and treatment of osteoporosis.//Osteoporosis Int. 1991. -№ l.-P. 114−117.
- Cooper C., Walker-Bone K., Arden N. et al. Novel insights into the pathogenesis of osteoporosis: the role of intrauterine programming. //Rheumatology. 2000. -№ 39. — P. 1312−1315.
- Cooper C., Eriksson J.G., Forson T. et al. Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. //Osteoporos. Int. -2001. -№ 12.-P. 623−629.
- Cooper C., Mitchell M., Wickham C. Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. //Ann. Rheum. Dis. 1995. — № 54. — P. 49 -52.
- Cosmi J.E. et al. Risk of the development of aortic stenosis in patients with «benign» aortic valve thickening. //Arch. Intern. Med. 2002. — № 162. — P. 2345−2347.
- Cummings S.R., Nevitt M.C., Browner W.S. et al. Risk factors for hip fracture in white women. Osteoporotic Fractures Research Group. //N. Engl. J. Med. 1995. — № 332. — P. 767 — 773.
- D’Amelio P., Grimaldi A., Pescarmona G. et al. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. //FASEB. J. 2004. — № 10. — P. 1096.
- Dargent-Molina P., Favier F., Grandjean H. et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. //Lancet. 1996. — № 34 (8).-P. 145−149.
- Dangas G., Khan S., Curry B.N. et al. Angina pectoris in severe aortic stenosis. //Cardiology. 1999. — № 92(1). — P. 1−3.
- Danilevicius C.F., Lopes J.B., Pereira R.M. Bone metabolism and vascular calcification. //Braz. J. Med. Biol. Res. 2007. — № 40(4). — P. 435−442.
- Das P., Pocock C., Chambers J. The patient with a systolic murmur: severe aortic stenosis may be missed during cardiovascular examination. //Q. J. Med. -2000.-№ 93.-P. 685−688.
- Davies M. Pathology of cardiac valves. //Boston, M.A.: Butterworth. -1980.-P. 18−35.tVi
- Davidson’s principles and practice of medicine. 18 edition. //Churchill Livingstone. 2000. — P. 868 — 870.
- Dean J., Lab M. Arrhythmia in heart failure: role of mechanically induced changes in electrophysiology. //Lancet. 1989. — № 1. — P. 1309−1312.
- Dellgren G., Eriksson M.J., Blange I. et al. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy. //Am. J. Cardiol. 1999. -№ 84. — P. 909−913.
- Delmas P.D., Eastell R., Garnero P. et al. The use of biochemical markers of bone turnover in osteoporosis. //Osteoporosis Int. 2000 — № ll (Suppl. 6). -P. 2−17.
- DeLuca H.F. The vitamin D story: a collaborative effort of basic science and clinical medicine. //FASEB. 1988. — № J2. — P. 224−236.
- Demer L.L. Boning up (or down) on statins. //Arterioscler. Thromb. Vase. Biol.-2001.-№ 21.-P. 1565 1566.
- Demer L.L. Lipid hypothesis of cardiovascular calcification. //Circulation. -1997.-№ 95.-P. 297−298.
- Demer LL. Cholesterol in vascular and valvular calcification. //Circulation. -2001.-№ 104.-P. 1881 1883.
- Demer L., Tintut Y. Mineral exploration: search for the mechanism of vascular calcification and beyond. //Arterioscl. Thromb. Vase. Biol. 2003. -№ 23.-P. 1739- 1743.
- Dennis M.S., Lo K.M., McDowall M., West T. Fractures after stroke: frequency, types, and associations. //Stroke. 2002. — № 33. — P. 728 -734.
- De Simone G., Pasanisi F., Contaldo F. Link of Nonhaemodynamic factors to haemodynamic determinants of left ventricular hypertrophy. //Hypertension. 2001. — № 38. — P. 13−18.
- Deutscher S., Rockette H.E., Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. //J. Chronic. Dis. 1984. — № 37. — P. 407−415.
- Doom van L., Lips P., Netelenbos J.C., Hackeng W.H.L. Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH (l-84)) in patients with primary hyperparathyroidism. //Bone Miner. -1993.-№ 23.-P. 233−242.
- Douglas P. S., Otto C.M., Mickel M.C.Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. //Br. Heart J. 1995. — № 73. — P. 548−554.
- Doherty M.J., Ashton B.A., Walsh S. et al. Vascular pericytes express osteogenic potential in vitro and in vivo. //J. Bone. Miner. Res. 1998. — № 13. -P. 828−838.
- Dressner-Pollak R., Parker R., Poku M. et al. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. //Calcif. Tissue Int.1996.-№ 59.-P. 328−333.
- Duda J.R.J., O’Brien J.F., Katzmann J.A. et al. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. //J. Clin. Endocrinol. Metab. 1988. — № 66. — P. 951−957.
- Dunn F., McLenachan J., Isles C. et al. LVH and mortality in hypertension: an analysis of data from the Glasgow blood pressure clinic. //J. Hypertens. 1990. — № 8. — P. 775−782.
- Dunn R.B., Griggs D.M. Ventricular filling pressure as a determinant of coronary blood flow during ischemia. //Am. J. Physiol. Heart. Circ. Physiol. -1983. № 244. — P. 429−436.
- Eastell R., Bauman M., Hoyle N.R. et al. Bone markers: biochemical and clinical perspectives. //Roshe. Martin Duntz. 2001. — P. 241 — 252.
- Eddy D., Johnston C., Cummings S.R. et al. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. //Osteoporosis Int. 1998. — № 8 (suppl 4). — P. 1 — 80.
- El-Maghraoui A., Mouinga-Abai D.A., Rkain H., Mounach A. Discordance in diagnosis of osteoporosis using spine and hip bone densitometry. //J. Clin. Densitom. 2007. — № 10(2). — P. 153−156.
- Endres D.B. Biochemical markers of bone metabolism. //J. of Clin. Ligand Assay. 1998. — № 21 (2). — P. 89 — 170.
- Enriquez-Sarano M., Rossi A., Seward J.B. et al. Determinance of pulmonary hypertension in left ventricular dysfunction. //J. Am. Coll. Cardiol.1997.-№ 29.-P. 153−159.
- Ensrud K.E., Palermo L., Black D.M. et al. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. //J. Bone. Miner. Res. 1995. — № 10. — P. 1778 -1787.
- Epstein S., Bryce G., Hinman J. et al. The influence of age on bone mineral regulating hormones. //Bone. 1986. — № 7. — P. 421−425.
- ESC working group report. Recommendations on the management of the asymptomatic patient with valvular heart disease. //Eur. Heart J. 2002. — № 23. -№ 16.-P. 1253−1266.
- Esposito G., Rapacciuolo A., Prasad S. et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. //Circulation. 2002. — № 105. — P. 85−92.
- European Study Group on Diastolic Heart Failure. European study group on diastolic heart failure working group report: how to diagnose diastolic heart failure. IIEur. Heart. J. 1998. — № 19. — P. 990−1003.
- Faggiano P., Aurigemma G.P., Rusconi C. et al. Progression of valvular aortic stenosis in adult: literature review and clinical implications. //Am. Heart J. 1996. — № 132. — P. 408−417.
- Faggiano P., Antonini-Canterin F. Progression of aortic valve sclerosis to aortic stenosis. //Am. J. Cardiol. 2003. -№ 91. — P. 99−101.
- Falcone C, Specchia G, Rondanelli R, et al. Correlation between beta-endorphin plasma levels and anginal symptoms in patients with coronary artery disease. // J. Am. Coll. Cardiol. 1998. — № 11. — P. 719−723.
- Feldman T., Glagov S., Carrol J.D. Restenosis following successful balloon valvuloplasty: bone formation in aortic valve leaflets. //Cathet. Cardiovasc. Diagn. 1993. — № 29 (1). — P. 1 — 7.
- Ferro G., Duilio C., Spinelli L. et al. Relation between diastolic perfusion time and coronary artery stenosis during stress induced myocardial ischemia. //Circulation. 1995. — № 92. — P. 342−347.
- Fondard O., Detaint D., lung B. et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. //Eur. Heart J. 2005. — № 26(13). — P. 1333 — 1341.
- Foreman D., Fulkerson P. Crystallochemical characteristics of the inorganic phase of human calcific aortic valvar stenosis. //Cardiovasc. Res. 1987. — № 21 (10).-P. 761 -765.
- Freeman R.V., Otto C.M. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. //Circulation. -2005. -№ 111.-P. 3316−3326.
- Frey N., Katus H.A., Olson E.N. et al. Hypertrophy of the heart. A new therapeutic target? //Circulation. 2004. — № 109. — P. 1580−1589.
- Frye M.A., Melton L.J. III, Bryant S.C. et al. Osteoporosis and calcification of the aorta. //Bone Miner. 1992. — № 19. — P. 185 — 194.
- Galante A., Pietroiusti A., Vellini M. et al. C-Reactive protein is increased in patients with degenerative aortic valvular stenosis. //J. Am. Coll. Cardiol. -2001. -№ 34.-P. 1078- 1081.
- Gamero P., Hausherr E., Chapuy M.C. et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. //J. Bone Miner. Res.-1996.-№ 11.-P. 1531 1538.
- Ganau A., Devereux R., Roman M. et al. Patterns of LVH and geometric remodeling in essential hypertension. //J. Am. Coll. Cardiol. 1992. — № 19. -P. 1550−1558.
- Garnero P. Markers of bone turnover for the prediction of fracture risk. // Osteoporosis Int. 2000. — № 11 (Suppl. 6). — P. 55 — 65.
- Garnero P., Borel O., Delmas P.D. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. //Clin. Chem. 2001. — № 47: — P. 694 — 702.
- Garcia D., Barenbrug P.J., Pibarot P. et al. A ventricular-vascular coupling model in presence of aortic stenosis. //Am. J. Physiol. Heart Circ. Physiol. — 2005. № 288(4). — P. HI 874 — HI 884.
- Garsia D., Dumesnil J.G., Durand L.-J. et al. Discrepancies between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon. //J. Amer. Coll. Cardiol. 2003. — №. 41.-P. 435−442.
- Ghaisas N.K., Foley J.B., O’Briain D.S. et al. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. //J. Am. Coll. Cardiol. 2000. — № 36. — P. 2257 — 2262.
- Giachelli C. Ectopic calcification. Gathering hard facts about soft tissue mineralization. //American Journal of Pathology. 1999. — Vol.154. — № 3. — P. 671 -675.
- Gibson D.G., Francis D.P. Clinical assessment of left ventricular diastolic function. //Heart. 2003. — № 89. — P. 231−238.
- Gibbons R.J., Beasley J.W., Bricker J.T. et al. ACC/AHA guidelines of exercise testing. Committee on exercise testing. //J. Am. Coll. Cardiol. 1997. -№ 30.-P. 260−311.
- Gerber I.L. et al. effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis. //Am. J. Cardiol. 2003. — № 92. — P. 1129−1132.
- Godman W.G., Salusky I.B., Juppner H. New lessons from old assays: PTH, its receptors and the potential biological relevance of PTH fragments. //Nephrol. Dial. Transplant. 2002. — 17. — P. 1731−1736.
- Gottlieb S., Harpaz D., Shotan A. Sex Differences in Management and Outcome After Acute Myocardial Infarction in the 1990s: A Prospective Observational Community-Based Study. // Circulation. 2000. — № 102. — P. 2484−2490.
- Gotto A.M. Statin Therapy and the Elderly SAGE Advice? //Circulation. -2007. -№ 115.-P. 681−683.
- Gould K.L., Carabello B.A. Why angina in aortic stenosis with normal coronary arteriograms? //Circulation. 2003. — № 107. — P. 3121−3123.
- Graafmans W.C., Ooms M.E., Hofstee H.M. et al. Falls in the elderly: a prospective study of risk factors and risk profiles. //Am. J. Epidemiol. 1996. -№ 143.-P. 1129−1136.
- Gregory Y.H., Lip G. Regression of left ventricular hypertrophy and improved prognosis. //Circulation. 2001. — № 104. — P. 1582 — 1584.
- Grisso J.A., Kelsey J.L., Strom B.L. et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. //N. Engl. J. Med. 1991.-№ 324.-P. 1326- 1331.
- Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in human left ventricle. //J. Clin. Invest. 1975. — № 56. — P. 5664.
- Grubb B.P., Kasinsky D. Serotonin and syncope: emerging connection. //Eur. J. Cardiac Pacing Electrophysiol. 1996. — № 5. — P. 306−314.
- Gunther S., Grossman W. Determinants of ventricular function in pressure overload hypertrophy in man. //Circulation. 1979. — № 59. — P. 679−688.
- Hainsworth R. Syncope: what is the trigger? //Heart. 2003. — № 89. — P. 123−124.
- Hak A.E., Pols H.A., van Hemert A.M. et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. //Arterioscler. Thromb. Vase. Biol. -2000.-№ 20.-P. 1926- 1931.
- Halloran B.P., Portale A.A., Lonergan E.T. Production and metabolic clearance of 1,25-dihydroxyvitamin D in men: effect of advancing age. //J. Clin. Endocrinal. Metab. 1990. -№ 70. — P. 318−326.
- Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. //Q.J.M. 2005. — № 98. — P. 467 — 484.
- Hasserius R., Karlsson M.K., Jonsson B. et al. Longterm morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly a 12 and 22 year follow up of 257 patients. //Calcif. Tissue Int. 2005. — № 76. — P. 235 242.
- Heaney R, Recker R. Combination and Sequential Therapy for Osteoporosis. //N. Engl. J. Med. 2005. — № 353. — P. 624 — 625.
- Heinrich R.S., Marcus R.H., Ensley A.E. et al. Valve orifice area alone is in insufficient index of aortic stenosis severity: effects of the proximal and distal geometry on transaortic energy loss. //J. Heart Valve Dis. 1999. — № 8. -P. 509−515.
- Henein M.Y., Gibson D.G. Long axis function in disease. //Heart. 1999. -№ 81.-P. 229−231.
- He Z., Hedrick T., Pratt C. et al. Severity of coronary artery calcification by Electron Beam Computed Tomography Predicts Silent Myocardial Ischemia. //Circulation 2000 — № 101 — P. 244−251.
- Hedstrom M., Svennson J., Dalen N. Biochemical bone markers and bone density in hip fracture patients. //Acta Orthop. Scand. 2000. — № 71. — P. 409 -413.
- Hill J.A., Karimi M., Kutscke W. et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. //Circulation. 2000. -№ 101.-P. 2863−2869.
- Hill J.A., Rothermel B.A., Yoo K.D. et al. Targeted inhibition of calcineurin in pressure-overload hypertrophy: preservation of systolic function. //J. Biol. Chem. 2002. — № 277. — P. 10 251−10 255.
- Hla M.M., Davis J.W., Ross P.D. et al. Relation between body composition and biochemical markers of bone turnover among early postmenopausal women. //J. Clin. Densitom. 2000. — № 3. — P. 365 — 371.
- Hoagland P.M., Cook F., Flatley M. et al. Case-control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older). //Am. J. Cardiol. 1985. — № 55. — P. 744−747.
- Hodsman A., Bauer D., Dempster D. et al. Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use. //Endocr. Rev. 2005. — № 26. — P. 688 -703.
- Holick M.F. Editorial: the parathyroid hormone D-Lema. // JCE & M. -2003. 88(8). — P. 3499−3500.
- Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. //Am. J. Clin. Nutr. 1995. — № 61(Suppl 3). — P 638S-645S.
- Horstkotte D., Loogen F. The natural history of aortic valve stenosis. IIEur. Heart J. 1988. — № 9. — P. 57−64.
- Hosking D.J., Geusens P., Rizzoli R. Osteoporosis therapy: an example of putting evidence-based medicine into clinical practice. //Q.J.M. 2005. — № 98.-P. 403−413.
- Hsia J., Heiss G., Ren H. et al. Calcium/Vitamin D Supplementation and Cardiovascular Events. //Circulation. 2007. — № 115. — P. 846−854.
- Imanaka S., Onishi T., Morimoto S. et al. Comparison for renal responses to synthetic human PTH (1−24) administration. //Calcif. Tissue Int. 1985. — № 37.-P. 357−362.
- Jackson J.A., Spiekerman A.M. Testosterone deficiency is common in men with hip fracture after simple falls. //Clin. Res. 1989. — № 37. — P. 131 — 136.
- Jeevanantham V., Singh N., Izuora K. et al. Correlation of high sensitivity C-reactive protein and calcific aortic valve disease. //Mayo Clin. Proc. 2007. — № 82(2).-P. 171−4.
- Jian B., Jones P.L., Li Q. et al. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. //Am. J. Pathol. 2001. — № 159. -P. 321−327.
- Jin X.Y., Gibson D.G., Pepper J.R. The relationship of myocardial stroke work to coronary flow velocity immediately after aortic valve replacement. //Ann. Thorac. Surg. 1999. -№ 67(3). — P. 705−710.
- Johnell O. Review: no single physical examination sign rules in or out osteoporosis or spinal fracture. //Evid. Based Med. 2005. — № 10. — P. 123.
- Jolobe O.M. Systolic murmur and aortic stenosis. Correspondence. //Q. J. Med.-2001.-№ 94.-P. 49.
- Jorde R., Sundsfjord J., Haug E., Bonaa K. Relation between low calcium intake, parathyroid hormone and blood pressure. //Hypertension. 2000. — № 35.-P. 1154−1159.
- Jorgensen L., Jacobsen B.K., Wilsgaard T., Magnus J.H. Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke: a longitudinal study. //Osteoporos. Int. 2000. — № 11. -P. 381−387.
- Kado D.M., Browner W.S., Blackwell T. et al. Rate of bone loss is associated with mortality in older women: a prospective study. //J. Bone Miner. Res.- 2000. -№ 15.-P. 1974−1980.
- Kadem L., Dumesnil J.G., Rieu R. et al. Impact of systemic hypertension on the assessment of aortic stenosis. //Heart. 2005. — № 91. — P. 354−361.
- Kamkin A., Kiseleva I., Pulaev A., et al. Cardiac fibroblasts a cellular substrate for mechanosensitivity in frog sinus venosus. //J. Physiol. (London) -1995.-№ 483.-P. 24.
- Kanis J., Oden A., Johnell O. Acute and long-term increase in fracture risk after hospitalization for stroke. //Stroke. 2001. — № 32. — P. 702 — 706.
- Kapoor W.N. Evaluation and management of the patient with syncope. //J.A.M.A. 1992. — № 268. — P. 2553−2560.
- Karpuz H., Ozsahin M., Aebisher N. Et al. Usefulness of the echocardiography velocity ratio for detection of significant aortic stenosis. //J. Amer. Coll. Cardiol. 1999. — № 84. — P. 1101 -1103.
- Karsenty G., Ducy P., Starbuck M. et al. Cbfal as a regulator of osteoblast differentiation and function. //Bone. 1999. — № 25. — P. 107 -108.
- Katoh Y., Klein K.L., Kaplan A. et al. Parathyroid hormone has a positive inotropic action in the rat. //Endocrinology. 1981. -№ 109. — P. 2252−4.
- Kawaguchi A., Miyatake K., Yutani C. et al. Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia. //Am. Heart J. 1999. — № 137. — P. 410−418.
- Kleerekoper M. Biochemical markers of bone turnover: why theory, research, and clinical practice are still in conflict. //Clinical Chemistry. 2001. -№ 8.-P. 1347- 1349.
- Klein R. Ventricular arrhythmias in aortic valve disease: analysis of 102 patients. //Am. J. Cardiol. 1984. — № 53. — P. 1079−1083.
- Kodama Y. Evolution of myocardial ischemia using Holter monitoring. //Fukuoka-Idaku-Zasshi. 1995. — № 86. — P. 304 — 316.
- Kohl P., Noble D. Mechanosensitive connective tissue: potential influence on heart rhythm. //Cardivasc. Rez. 1996. — № 32. — P. 62−68.
- Kondratjev D., Pulaev A., Kiseleva I., et al. Mechanosensitive electrically non-excitable cells in the atria of the frog and rat heart. //J. Physiol. (London) -1993.-№ 473.-P. 258.
- Kong Y.Y., Boyle W.J., Penninger J.M. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. //Immunol. Today. 2000. — № 21. -P. 495−502.
- Kolta S., Ravaud P., Fechtenbaum J. et al. Accuracy and precision of 62 bone densitomers using a European Spine Phantom. //Osteoporos. Int. 1999. -№ 10.-P. 14−19.
- Koren M., Devereux R., Casale P. et al. Relation of LV mass and geometry to morbidity and mortality in complicated essential hypertension. //Ann. Intern. Med.-1991.-№ 114.-P. 345−352.
- Kowey P., Friehling Т., Sewter J. et al. Electrophysiological effects of LVH. //Circulation. 1991. — № 83. — P. 2067−2075.
- Krayenbuehl H.P., Hess O.M., Monrad E.S. et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. //Circulation. 1989. — № 79. — P. 744−755.
- Kuehn B. Evidence-based guidelines needed for osteoporosis screening and treatment. //J.A.M.A. 2005. — № 294. — P. 34.
- Kuller L.H., Matthews K.A., Sutton-Tyrrell K. et al. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the healthy women study. //Arterioscler. Thromb. Vase. Biol. — 1999.-№ 19.-P. 2189−2198.
- Kupari M., Turto H., Lommi J. LVH in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? //Eur. Heart J. 2005. — № 26.-P. 1790−1796.
- Kvidal P., Bergstrom R., Horte L.G., Stanhle E. Observed and relative survival after aortic valve replacement. //J. Am. Coll. Cardiol. 2000. — № 35. -P. 747−756.
- Ledger G.A., Burritt M.F., Kao P.C. et al. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with l, 25-(OH)2D. //J. Clin. Endocrinol. Metab. 1994. — № 79. — P. 211−216.
- Lee Y.S., Chou Y.Y. Pathogenetic mechanism of senile calcific aortic stenosis: the role of apoptosis. //Chin. Med. J. 1998. — № 111 (10). — P. 934 -939.
- Levine R.A. Dynamic mitral regurgitation more than meets the eye. //N. Engl. J. Med. — 2004. — № 351. — P. 1681 -1684.
- Lip G. Regression of left ventricular hypertrophy and improved prognosis. //Circulation.-2001.-№ 104.-P. 1582-.1584.
- Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. //Endocrine reviews. 2001. — № 22(4). — P. 477−501.
- Lips D.J., DeWindt L.J., van Kraaij D.J. et al. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. //Eur. Heart J. 2003. — № 24. — P. 883−896.
- Lindroos M., Kupari M., Valvanne J. et al. Factors associated with calcific aortic valve degeneration in the elderly. //Eur. Heart J. 1994. — № 15. — P. 865−870.
- Lindroos M.3 Kupari M., Heikkila J. et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. //J. Am. Coll. Cardiol. 1993. -№ 21. — P. 1220−1225.
- Livanainen A.M., Lindroos M., Tilvis R. et al. Natural history of aortic valve stenosis of varying severity in the elderly. //Am. J. Cardiol. 1996. — № 78.-P. 97−101.
- Liu Y., Dvornyk V., Lu Y. et al. A Novel Pathophysiological Mechanism for Osteoporosis Suggested by an in vivo Gene Expression Study of Circulating Monocytes. //J. Biol. Chem. 2005. — № 280. — P. 29 011 — 29 016.
- London G.M., De Vernejoul M.C., Fabiani F. et al. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. //Kidney Int. 1987. — № 32. — P. 900−907.
- Long C., Hartogenesis W., Simpson P. Beta-adrenergetic stimulation of cardiac non-myocytes augments the growth promoting activity of non-myocyte conditioned medium.// J. Mol. Cell. Cardiol. 1993. — № 25. — P. 915−925.
- Ludbrook J. Hemorrhage and shock. //In cardiovascular reflex control in health and disease. London: Sounders. — 1993. — P. 463−490.
- Lund O., Kristensen A., Baandrup U. et al. Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. //Eur. Heart. J. 1998. -№ 19.-P. 1099- 1108.
- Ma J., Johns R.A., Stafford R.S. Americans are not meeting current calcium recommendations. //Am. J. Clin. Nutr. -2007. 85(5). P. 1361−1366.
- MacMahon S.W., Wilcken D.E., Macdonald G.J. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. //N. Engl. J. Med. 1986. — № 314. — P. 334 339.
- Manolis A.S., Linzer M., Salem D. et al. Syncope: current diagnostic evaluation and management. //Ann. Intern. Med. 1990. — № 112. — P. 850 863.
- Mann D., Usher B.W., Hammerman S. et al. The fractional shottening-velocity ratio: validation of a new echocardiographic Doppter method for identifying patients with significant aortic stenosis. //J. Amer. Coll. Cardiol. -1990. -№ 15.-P. 1578−1584.
- Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. //B.M.J. -1996.-№ 312. -P. 1254- 1259.
- Martin-Du P.R., Pruijm M. Metabolic and endocrine effects of antihypertensive drugs.//Rev. Med. Suisse. 2007. — № 14. — P. 681−684.
- Martos R., Baugh J., Ledwidge M. et al. Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction. //Circulation. 2007. — № 115.-P. 888−895.
- Marcus R., Madvig P., Young G. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. //J. Clin. Endocrinol. Metab. 1984. — № 58. — P. 223−230.
- Massie BM, Szlachcic Y, Tubau JF, O’Kelly BF, Ammon S, Chin W. Scintigraphic and electrocardiographic evidence of silent coronary artery disease in asymptomatic hypertension: a case-control study. //J. Am. Coll. Cardiol. 1993. — № 22 — P. 1598−1606.
- Mathew J., Sleight P., Lonn E. et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of LVH by the angiotensin converting enzyme inhibitor, ramipril. //Circulation. 2001. — № 104. — P. 1615−1621.
- Matsumura Y., Takata J., Yabe T. et al. Atherosclerotic aortic plaque detected by transesophageal echocardiography: its significance and limitationas a marker of coronary artery disease in the elderly. //Chest. 1997. — № 112. -P. 81−86.
- Matthews A., Barritt D., Keen G. et al. Preoperative mortality in aortic stenosis. //Br. Heart J. 1974. -№ 36. -P. 101−103.
- Mautner G.C., Mautner S.L., Cannon R.O. et al. Clinical factors useful in predicting aortic valve structure in patients > 40 years of age with isolated valvular stenosis. //Am. J. Cardiol. 1993. — № 72 (2). — P. 194−198.
- Mautner G.C., Mautner S.L., Froehlich J. et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. //Radiology. 1994. — № 192. — P. 619 — 623.
- Mazzone A., Mazzucchelli I., Vezzoli M. et al. Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia. //J. Am. Coll. Cardiol. 2000. — № 36. — P. 746−750.
- Mazzone A., Cusa C., Mazzucchelli I. et al. Increased production of inflammatory cytokines in patients with silent myocardial ischemia. //J. Am. Coll. Cardiol.-2001.-№ 38.-P. 1895−1901.
- McKenna M. Differences in vitamin D status between countries in young adults and the elderly. //Am. J. Med. 1992. — № 93. — P. 69−77.
- Melton III L.J., Atkinson E.J., O’Connor M.K. et al. Determinants of bone loss from the femoral neck in women of different ages. //J. Bone Miner. Res. -2000.- 15.-№ 24.-P. 31.
- Messika-Zeitoun D., Bielak L. F., Peyser P. A. et al. Aortic Valve Calcification: Determinants and Progression in the Population. //Arterioscler. Thromb. Vase. Biol. 2007. — № 27(3). — P. 642 — 648.
- Meller ST, Gebhart GF. Silent ischemia: a hypothetical mechanism.// Neurosci. Biobehav. Rev. 1993. -№ 17. — P. 229−236.
- Melton L.J., Chrischilles E.A., Cooper C. et al. Perspective. How may women have osteoporosis? //J. Bone. Miner. Res. 1992. — № 7. — P. 1005 -1010.
- Meyer H.E., Henriksen C., Falch J.A. et al. Risk factors for hip fracture in a high incidence area: a case-control study from Oslo, Norway. //Osteoporos. Int. 1995.-№ 5.-P. 239−246.
- Middlekauff H.R., Stevenson W.G., Saxon L.A. Prognosis after syncope: impact of left ventricular function. //Am. Heart J. 1993. — № 125. — P. 121 127.
- Michos E.D., Blumenthal R.S. Vitamin D Supplementation and Cardiovascular Disease Risk. // Circulation. 2007. — № 115(7). — P. 827 — 828.
- Milcent G., Dormont B., Durand-Zaleski I., Steg P.G. Gender Differences in Hospital Mortality and Use of Percutaneous Coronary Intervention in Acute Myocardial Infarction. // Circulation. 2007. — № 115. — P. 833−839.
- Minisola S., Pacitti M., Scarda A. et al. Serum ionized calcium, parathyroid hormone and related variables: effect of age and sex. //Bone Miner. 1993. — № 23.-P. 183−193.
- Mohler E.R., Sheridan M.J., Nichols R. et al. Development and progression of aortic valve stenosis: atherosclerosis risk factors—a causal relationship? //Clin. Cardiol. 1991. -№ 14. — P. 995−999.
- Mohler E.R. Are atherosclerotic processes involved in aortic-valve calcification? // Lancet. 2000. — № 356. — № 524 — 525.
- Mohler E.R., Chawla M.K., Chang A.W. et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. //J. Heart. Valve Dis. 1999. — № 8. — P. 254 — 260.
- Mohler E.R. III. Aortic valve calcification: how and why? //A.C.C. current journal review. 2001. — May/June. — P. 84' - 85.
- Monrad E.S., Hess O.M., Murakami T. et. al. Time course of regression of left ventricular hypertrophy after aortic valve replacement. //Circulation. -1988.-№ 77.-P. 1345−1355.
- Morgan H.E., Baker K.M. Cardiac hypertrophy. //Circulation. 1993. — № 83.-P. 13−25.
- Mussolino M.E., Madans J.H., Gillum R.F. Bone mineral density and stroke. //Stroke. 2003. — № 34. — P. 20−22.
- Nademanee K, Intarachot V, Singh PN, Josephson MA, Singh BN. Characteristics and clinical significance 'of silent myocardial ischemia in unstable angina. //Am. J. Cardiol. 1986. — № 58. — P. 26B-33B.
- Nair C.K., Sudhakaran C., Aronow W.S. et al. Clinical characteristics of patients younger than 60 years with mitral annular calcium: comparison with age- and sex-matched control subjects. //Am. J. Cardiol. 1984. — № 54. — P. 1286−1287.
- Nappi S., Saha H., Virtanen V. et al. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. //Cardiology. 2000. — № 4. — P. 229−233.
- Need A.G., O’Loughlin P.D., Morris H.A. et al. The effects of age and other variables on serum parathyroid hormone in postmenopausal women attendingan osteoporosis center. //J. Clin. Endocrinol. Metab. 2004. — № 089. — P. 16 461 649.
- Nestico P.F., Depace N.L., Morganroth J. et al. Mitral annular calcification: clinical, pathophysiology, and echocardiographic review. //Am. Heart. J. -1984. -№ 107. -P. 989−996.
- Newby D.E., Cowell S.J., Boon N.A. Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both? //Heart. 2006. — № 92(6). — P. 729−734.
- Nielsen H.K., Brixen K., Mosekilde L. Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season and smoking habits. //Calcif. Tissue Int. 1990. — № 47. — P. 284−290.
- Nieves J. Osteoporosis: the role of micronutrients. //Am. J. Clinical Nutrition. 2005. -№ 81. — P. 1232S — 1239S.
- Norman A.W., Roth J., Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). //Endocr. Rev. 1982. — № 3. — P. 331−366.
- Novaro G., Sachar R., Pearce G. et al. Association between apolipoprotein E alleles and calcific valvular heart disease. //Circulation. 2003. — № 108. — P. 1804−1806.
- Nylander E., Ekman I., Marklund T. et al. Severe aortic stenosis in elderly patients. //Br. Heart J. 1986. — № 55. — P. 480−487.
- O’Brien K.D., Kuusisto J., Reichenbach D.D. et al. Osteopontin is expressed in human aortic valvular lesions.' //Circulation. 1995. — № 92. — P. 2163−2168.
- O’Brien K.D., Reichenbach D.D., Marcovina S.M. et al. Apolipoproteins B, (a) and E accumulate in the morphologically early lesion of «degenerative» valvular aortic stenosis. //Arterioscler. Thromb. 1996. — № 16. — P. 523 -532.
- Oberg B., Thoren P. Increased activity in left ventricular receptors during hemorrhage or occlusion of the caval veins in the cat. A possible causes of the vasovagal reaction. //Acta Physiol. Scand. 1972. — № 85. — P. 164−173.
- O’Keete J.H., Lavie C.J., Nishimura R.A., Edvards W.D. Degenerative aortic stenosis: one effect of the graying of America. //Postgrad. Med. J. -1991. -№ 89.-P. 143- 154.
- Ollson L.J., Subramanian R., Askermann D.M. et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. //Mayo Clin. Proc. -1987.-№ 62.-P. 22−34.
- Olsson M., Dalsgaard C.J., Haegerstrand A. et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. //J. Am. Coll. Cardiol. 1994. — № 23. — P. 1162 -1170.
- Olsson M., Thyberg J., Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. //Arterioscler. Thromb. Vase. Biol.-1999.-№ 19.-P. 1218- 1222.
- Olshansky B. Syncope: overview and approach to management. //In Syncope: mechanisms and management. Armonk N.Y.: Futura. — 1998. — P. 15−71.
- Omdahl J.L., Garry P.J., Hunsaker L.A. et al. Nutritional status in a healthy elderly population: vitamin D. //Clin. Nutr. 1982. — № 36. — P. 1225−1233.
- Orwoll E., Ettinger M., Weiss S. et al. Alendronate for the treatment of osteoporosis in men. //N. Engl. J. Med. 2000. — № 343. — P. 604 — 610.
- Orwoll E., Meier D. Alterations in calcium, vitamin D and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. //J. Clin. Endocrinol. Metab. 1986. — № 63. — P. 12 621 269.
- Otto C.M., Burwash I.G., Legget M.E. et al. Prospective study of asymptomatic valvular aortic stenosis. //Circulation. 1997. — № 95. — P. 22 622 270.
- Otto C., O’Brien K.D. Why is there discordance between calcific aortic stenosis and coronary artery disease? //Heart. 2001. — № 85. — P. 601−602.
- Otto C.M., Kuusisto J., Reichenbach D. et al. Characterisation of the early lesion of «degenerative» valvular aortic stenosis: histological and immunohistochemical studies. //Circulation. 1994. — № 90. — P. 844 — 853.
- Otto C.M., Lind B.K., Kitzman D.W. et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. //N. Engl. J. Med. 1999. — № 341. — P. 142 — 147.
- Otto C. Aortic stenosis: listen to the patient, look at the valve. //N. Engl. J. Med. 2000. — Vol. 343. — № 9. — P. 652 — 654.
- Otto C.M. Valvular regurgitation: diagnosis, quantitation and clinical approach. //In «Textbook of clinical echocardiography», 2nd ed., Phyladelphia: WB Saunders. 2000. — P. 265−300.
- Otto C.M., Aikawa K. Timing of surgery in aortic stenosis. //Progress in cardiovascular diseases. 2001. — Vol. 43. — № 6. — P. 477−493.
- Otto C.M. Timing of surgery in mitral regurgitation. //Heart. 2003. — № 89.-P. 100−105.
- Pachulski RT, Weinberg AL, Chan KL. Aortic anevrysm in patients with functionally normal or minimally stenotic bicuspid aortic valve. //Am. J. Cardiol. 1991.-№ 67.-P.781−782.
- Pai R.G., Kapoor N., Bansal R.C., Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. //Ann. Thorac. Surg. 2006. — № 82(6). — P. 2116−2122.
- Palmieri V., Watchtell K., Gerdts E. et al. LV function and haemodynamic features of inappropriate LVH in patients with systemic hypertension. //Am. Heart J.-2001.-№ 141.-P. 784−791. .
- Palta S., Pai A.M., Gill K.S. et al. New insights into the progression of aortic stenosis: implications for secondary prevention. //Circulation. 2000. -№ 101.-P. 2497−2502.
- Papai JL, Masters RG, Walley VM, Stinson WA, Veinot JP. Aortic medial changes associated with bicuspid aortic valve: myth or reality? //Can. J. Cardiol. 1999. — № 15. — P.1233−1238.
- Parfitt A.M., Rao D.S., Stanciu J. et al. Irreversible bone loss in osteomalacia: comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. //J. Clin. Invest. 1985. — № 76. — P. 2403−2412.
- Parfitt A.M. Morphologic basis of bone mineral measurements. //Miner. Electrolyte Metab. 1980. — № 4. — P. 273−287.
- Parhami F., Garfinkel A., Demer L. Role of lipids in osteoporosis. //Arterioscler. Thromb. Vase. Biol. 2000. — № 20. — P. 2346 — 2348.
- Pawlikowski M., Pfitzner R. Mineralization of heart valves. //Folia. Med. Cracov. 1992. — № 33 (1−4). — P. 3 — 24.
- Pellica P.A., Sarano M.E., Nishimura R.A. et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. //Circulation. 2005. — № 111. — P. 3290−3295.
- Peltier M., Tribouilloy C. Prevention of calcific aortic stenosis by statins: myth or reality? //Arch. Mai. Coeur. Vaiss. 2006. — № 99(9). — P. 818−22.
- Peltier M., Trojette F., Enriquez-Sarano M. et al. Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve. //Am. J. Cardiol. 2003.- № 91.-P. 97−99.
- Petrie M.C., Caruana L., Berry C. et al. Diastolic heart failure or heart failure caused by subtle left ventricular systolic dysfunction. //Heart. 2002. — № 87. -P. 29−31.
- Pfeifer M., Begerow B., Minne H. et al. Effects of short term vitamin D and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. //J. Clin. Endocrinol. Metab. 2001. — № 86. — P. 1633−1637.
- Pierard L.A., Lancelotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. /IN. Engl. J. Med. 2004. — № 351. -P. 1627−1634.
- Poggianty E. et all. Aortic valve sclerosis is associated with systemic endothelial disfunction. //J.A.C.C. -2003. -№ 41. -P. 136−131.
- Potts J.T. Parathyroid hormone: past and present. //Journal of endocrinology. -2005. -№ 187.-P. 311−325.
- Price P.A., June H.H., Buckley J.R., Williamson M.K. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. //Arterioscler. Thromb. Vase. Biol. 2001. — № 21. — P. 1610 — 1616.
- Pye M., Cobbe S. Arrhythmogenesis in experimental models of heart failure: the role of increased load. //Cardivasc. Res. 1996. — № 31. — P. 873 881.
- Quinn D.W., Spinier S.A. Efficacy of statins in preventing progression of aortic stenosis. // Am. J. Health Syst. Pharm. 2005. — № 62(9). — P. 979 — 981.
- Rahimtoola S.H. Indication for surgery in aortic valve disease. //In Evidence based cardiology. B.MJ. Publishing. — 1998. — P. 811−832.
- Rahimtoola S.H. Severe aortic stenosis with low systolic gradient. The good and bad news. //Circulation. 2000. — № 101. — P. 1892−1894.
- Raisz L., Smith J.A., Trahiotis M. et al. Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover. //Osteoporos. Int. 2000. — № 11. — P. 615 — 620.
- Raisz L.G. Screening for Osteoporosis. //N. Engl. J. Med. 2005. — № 353. -P. 164−171.
- Rajamannan N.M., Bonow R.O., Rahimtoola S.H. Calcific aortic stenosis: an update. //Nat. Clin. Pract. Cardiovasc. Med. 2007. — № 4(5). — P. 254−62.
- Rajamannan N., Subramaniam M., Rickard D. et al. Human aortic valve calcification is associated with an osteoblast phenotype. //Circulation. 2003. -№ 107.-P. 2181 -2184.
- Ramnemark A., Nilsson M., Borssen B., Gustafson Y. Stroke, a major andincreasing risk factor for femoral neck fracture. //Stroke. 2000. -№ 31.— P. 1572−1577.
- Reichel H., Koeffler H.P., NormanA.W. The role of the vitamin D endocrine system in health and disease. //N. Engl. J. Med. 1989. — № 320. — P. 980−991.
- Rembert J.C., Kleinman L.H., Fedor J.M. et al. Myocardial blood flow distribution in concentric left ventricular hypertrophy. //J. Clin. Invest. 1978. -№ 62.-P. 379−386.
- Riggs B.L., Melton L.I., O’Fallon W.M. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. //Bone. 1996. — № 18 (Suppl. 3). -P. 197S-201S.
- Rispler S., Rinkevich D., Markiewicz L. Missed diagnosis of severe symptomatic aortic stenosis. //Am. J. Cardiol. 1995. -№ 76. — P. 728−730.
- Roberts WC. The congenitally bicuspid aortic valve: a study of 85 autopsy cases. //Am. J. Cardiol. 1970. — № 26. — P. 72−83.
- Roberts W.S. The senile cardiac calcification syndrome. //Am. J. Cardiol. -1986.-№ 58.-P. 572−574.
- Rosen C.J. Postmenopausal Osteoporosis. //N. Engl. J. Med. 2005. — № 353.-P. 595−603.
- Rosenhek R., Binder T., Porenta G. et al. Predictors of outcome in severe, asymptomatic aortic stenosis. //N. Engl. J. Med. 2000. — № 343. — P. 611−617.-299 429. Rosenhek R. Statins for aortic stenosis. //N. Engl. J. Med. 2005. — № 352.-P. 2441−2443.
- Rosenhek R., Klaar U., Schemper M. et al. Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. //Eur. Heart J. 2004. — № 25. — P. 199−205.
- Ross J., Braunwald E. Aortic stenosis. //Circulation. 1968. — № 38 (suppl. 1).-P. 61−67.
- Ross P.D., Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. //J. Bone Miner. Res. 1997. — № 13. — P. 297−302.
- Rossi A., Tomaino M., Golia G. et al. Echocardiographic prediction of clinical outcome in medically treated patients with aortic stenosis. //Am. Heart J. 2000. — № 140.-P. 766−771.
- Royal College of Physicians. Osteoporosis: clinical guidelines for prevention and treatment. //London.: Royal College of Physicians. 1999.
- Ruwhof C. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. //Cardiovasc. Res. 2000. — № 47. — P. 23−37.
- Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ. Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease. //Am. J. Respir. Crit. Care Med. -2007. -№ 15.-P. 22−24.
- Sadoshima J., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. //Ann. Rev. Physiol. 1997. — № 59. — P. 551 571.
- Salcedo E.E., Korzik D.H., Currie P.J. et al. Determinants of left ventricular hypertrophy in aortic valve stenosis. //Cleve. Clin. J. Med. 1989. — № 56. — P. 590−596.
- Sanderson J.E. Diastolic heart failure: fact or fiction. //Heart. 2003. — № 89.-P. 1281−1282.
- Sarphie T.G. Surface responses of aortic valve endothelia from diet-induced, hypercholesterolemic rabbits. //Atherosclerosis. 1985. — № 54. — P. 283−299.
- Sato S., Ohta M., Kawaguchi Y. et al. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. //Miner. Electrolyte Metab. 1995.-№ 21.-P. 67−71.
- Scheler S, Motz W, Strauer BE. Transient myocardial ischaemia in hypertensives: missing link with left ventricular hypertrophy. //Eur. Heart J. — 1992.-№ 13.-P. 62−65.
- Schievink WI, Mokri B. Familial aorto-cervicocephalic arterial dissection and congenitally bicuspid aortic valve. //Stroke. 1995. — № 26. — P. 19 351 940.
- Schneider D.L., Barret-Connor E.L. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. //Arch. Intern. Med. 1997. — № 157. — P. 1241−1245.
- Schumok G.T., Sprague S.M. Clinical and economic burden of fractures in patients with renal osteodystrophy. //Clin. Nephrol. 2007. — № 67(4). — P. 201−208.
- Schluter K.D., Millar B.C., McDermott B.J. et al. Regulation of protein synthesis and degradation in adult ventricular cardiomyocytes. //Am. J. Physiol. 1995. — № 269. — P. 1347−55.
- Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized doubleblind studies.//JAMA. 1996. — № 275.-P. 1507−1513.
- Schoppet M., Preissner K., Hoftbauer L. RANK ligand and Osteoprotegerin. Paracrine regulators of bone metabolism and vascular function. //Arterioscler. Thromb. Vase. Biol. 2002. — № 22. — P. 549 — 553.
- Schrire V. Aortic stenosis. //In Schrire V., ed. Clinical cardiology, 3rd edn. -London, Staples Press. 1971. — P. 395 — 398.
- Schulz E., Arfai K., Liu X. et al. Aortic Calcification and the Risk of Osteoporosis and Fractures. //J. Clin. Endocrinol. Metab. 2004. — № 89. — P. 4246 — 4253.
- Schunkert H., Sadoshima J., Cornelius T. et al. Angiotensin II induced growth responses in isolated adult rat hearts. //Circ. Res. 1995. — № 76. — P. 489−497.
- Seiler C., Jenni R. Severe aortic stenosis without left ventricular hypertrophy. //Heart. 1996. — № 76. — P. 250−255.
- Sennerby U., Farahmand B., Ahlbom A. et al. Cardiovascular diseases and future risk of hip fracture in women. //Osteoporos. Int. 2007. — № 10. — P. 1218.
- Shavelle D. M. Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis? //Heart/ 2005. — № 91(10). — P. 1257 — 1259.
- Shen H., Bielak L.F., Streeten E.A. et al. Relationship between Vascular Calcification and Bone Mineral Density in the Old-Order Amish. //Calcif. Tissue Int. 2007. — № 80(4). — P. 244−250.'
- Sherman S., Hollis B., Tobin J. Vitamin D status and related parameters in a healthy population: the effects of age, sex and season. //J. Clin. Endocrinol. Metab. 1990. — № 71. — P. 405−413.
- Silaruks S., Clark D., Thinkhamrop B. et al. Angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. //Heart Lung Circ. -2001.-№ 10(1).-P. 14−23.
- Skowasch D., Schrempf S., Preusse C. J. et al. Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive proteinconcentrations and modification by statins. //Heart. 2006. — № 92(4). — P. 495 -498.
- Stefenelli T., Mayr H., Berger-Klein J. et al. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. //Am. J. Med. 1993. — № 95. — P. 197−202.
- Stefenelli T., Abela C., Frank H. et al. Cardiac abnormalities in patients with primary hyperparathyroidism. //J. Clin. Endocrinol. Metab. 1997. — № 82. — P. 106−112.
- Stewart B.F., Siscovick D., Lind B.K. et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study (CHS). //J. Am. Coll. Cardiol. 1997. — № 29. — P. 630−634.
- Sehran C.N. Clues for new therapeutics in osteoporosis. //N. Engl. J. Med. -2004. № 350. — P. 1902 — 1903.
- Seibel MJ. Molecular markers of bone turnover: biochemical, technical and analytical aspects. //Osteoporosis Int. 2000. — № 11 (Suppl. 6). — P. 45 — 54.
- Sell S., Scully R. Aging changes in the aortic and mitral valves. //Am. J. Pathol. 1956. — № 46. — P. 345−365.
- Selzer A. Changing aspects of the natural history of valvular aortic stenosis. IIN. Eng. J. Med. 1987. -№ 317. — P. 91−98.
- Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. //Am. J. Cardiol. 1997. — № 79. — P. 17−23.
- Shalev Y., Gal R., Tchou P J. et al. Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head up tilt. //J. Am. Coll. Cardiol. 1991. — № 18. -P. 746 -751.
- Siegel D, Cheitlin MD, Seeley DG, Black DM, Hulley SB. Silent myocardial ischemia in men with systemic hypertension and without clinical evidence of coronary artery disease. // Am. J. Cardiol. 1992. — № 70. — P. 8690.
- Silver M. Cardiovascular pathology. 2nd ed. //New York, N.Y.: Churchill Livingstone. 1991. — P. 989−1001.
- Slight S., Ganjam V., Nonneman D., et al. Glucocorticoid metabolism in the cardiac intestitium: 11 (-hydroxysteroid dehydrogenase activity in cardiac fibroblasts. //J. Lab. Clin. Med. 1993. — № 122. — P. 180−187.
- Sokolow M., Perloff D. The prognosis of essential hypertension treated conservatively. //Circulation. 1961. — № 23. — P. 697−713.
- Sorgato A., Faggiano P., Rusconi C. et al. Ventricular arrhythmias in adult aortic stenosis.//Chest. 1998.-№ 113.-P. 482−491.
- Stafford R., Drieling R., Hersh A. National Trends in Osteoporosis Visits and Osteoporosis Treatment. //Archives of Internal Medicine. 2004. — № 164. -P. 1525−1530.
- Stein C. The control of pain in peripheral tissue by opioids.// N. Engl. J. Med. 1995.-№ 332.-P. 1685−1690.
- Stewart B.F., Siscovick D., Lind B.K. et al. Clinical factors associated with calcific aortic valve disease. //J. Am. Coll. Cardiol. 1997. — № 29. — P. 630 634.
- Stokes W. The diseases of the heart and aorta. //Dublin.: Hodges & Smith. -1845.-P. 211−212.
- Stulc T., Ceska R., Horinek A., Stepan J. Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotype. //Physiol. Res. 2000. — № 49.-P. 435−439.
- Susik D., Nunez E., Frohlich E. et al. Angiotensin II increases LV mass without affecting myosine isoform mRNAs. //Hypertension. 1996. — № 28. -P. 265−268.
- Tanaka K., Sata M., Fukuda D. et al. Age-Associated Aortic Stenosis in Apolipoprotein E-Deficient Mice. // J. Am. Coll. Cardiol. 2005. — № 46(1). -P. 134−141.
- Tanaka N., Ryoke T., Hondo M. et al. Effects of growth hormones end IGF-1 on cardiac hypertrophy and gene expression in mice. //Am. J. Physiol. -1998. № 275 (2). — P. 393−399.
- Tanimura A., McGregor D.H., Anderson H.C. Matrix vesicles in atherosclerotic calcification. //Pros. Soc. Exp. Biol. Med. 1983. — № 172. — P. 173- 177.
- Tannenbaum C., Clark J., Schwartzman K. et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. //J. Clin. Endocrinol. Metab. 2002. — № 87. — P. 4431−4437.
- Tenenbaum A., Fisman E., Schwammenthal E. et al. Aortic valve calcification in hypertensive patients: prevalent risk factors and association with transvalvular flow velocity. //Int. J. Cardiol. 2004. — № 94 (1). — P. 7−13.
- Tentolouris C., Kontozoglou T., Toutouzas P. Familial calcification of aorta and calcific valve disease associated with immunologic abnormalities. //Am. Heart J. 1993,-№ 126.-P. 904−909.
- Terpstra WF, May JF, Smit AJ et al. Silent ST depression and cardiovascular end-organ damage in newly found, older hypertensives. //Hypertension. 2001. — № 37. — P. 1083−1088.
- Tuck SP., Francis RM. Osteoporosis. //Postgrad. Med. J. 2002. — № 78. -P. 526−532.
- United Nations Population Division. World population prospects: The 1998 revision. //New York: Population Division of the Department of Economic and Social Affairs of the United Nations. 1998.
- Vasan R.S., Levy D. Defining diastolic heart failure: a call for diagnostic criteria. //Circulation. 2000. — № 101. — P. 2118−2121.
- Veinot J.P. Non-unifirm aortic medial degenerative changes associated with aortic valve disease. //Eur. J. Cardio-thorac. Surg. 2002. — № 4. — P.1036−1037.
- Vieth R., Cole D., Krege J. et al. Teriparatide, Osteoporosis, Calcium, and Vitamin D. IIN. Engl. J. Med. 2005. — № 353. — P. 634 — 635.
- Villary B., Campbell S.E., Hess O.M. et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. 111. Am. Coll. Cardiol. 1993. — № 22. — P. 1477 — 1484.
- Wackers F., Young L., Inzucchi S. et al. Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects (DIAD study). //Diabetes Care -2004.-№ 27.-P. 1954−1961.
- Wagman R.B., Marcus R. Editorial: beyond bone mineral density -navigating the laboratory assessment of patients with osteoporosis. //J. Clin. Endocrinol. Metab. 2002. — № 87 (10). — P. 4429 — 4430.
- Wallach S., Cohen S., Reid D.M. et al. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. //Calcif. Tissue. Int. 2000. — № 67. — P.277 — 285.
- Walther T., Schubert A., Falk V. et all. Regression of LVH after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression. //Circulation. 2001. — № 104 (suppl. 1) — P. 54−58.
- Wang A.Y., Woo J., Wang M. et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. //J. Am. Soc. Nephrol. 2001. — № 12. — P. 1927 -1936.
- Wang M., Yip G.W., Wang A. Y et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. //J. Am. Coll. Cardiol. 2003. — № 41. — P. 820−826.
- Watts N.B. Clinical utility of biochemical markers of bone remodeling. //Clinical chemistry 45. 1999. — № 8 (B). — P. 1359 — 1368.
- Webb A.R., Kline L., Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3. //J. Clin. Endocrinol. Metab. 1988. — № 67.-P. 373−378.
- Weber K. Extracellular matrix remodeling in heart failure. //Circulation. -1997. № 96. — P. 4065−4082.-307 512. Weiss R. Another calcium paradox? //Arterioscler. Thromb. Vase. Biol. — 2001.-№ 21.-P. 1561 1562.
- Wilmshurst P.T., Stevenson R.N., Griffiths H., Lord J.R. A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis. //Heart. 1997. — № 78. — P. 475−479.
- Wolff I., van Croonenborg J.J., Kemper H.C. et al. The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. //Osteoporos. Int. 1999. — № 9. — P. 1 — 12.
- Wu B., Elmariah S., Kaplan F.S. et al. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts. //Aiterioscler. Thromb. Vase. Biol. — 2005.-№ 25.-P. 592−597.
- Xie G.Y., Berk M.R., Smith M.D. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. //J. Am. Coll. Cardiol. — 1994.-№ 24.-P. 132−139.
- Yamazaki T., Komuro I., Kudoh S. et al. Mechanical stress activates PKC of phosphorylation in neonatal rat cardiac myocites. //J. Clin. Invest. 1995. -№ 96.-P. 438−446.
- Yip G.W.K., Wang M., Zhang Y. et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition. //Heart. 2002. — № 87. — P. 121−125.
- Yiu S.F., Enriquez-Sarano M., Tribouilloy C. et al. Determinance of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. //Circulation. 2000. — № 102. — P. 1400 -1406.
- Yu H.C.M., Sanderson J.E. Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure. //Clin. Cardiol. 1999. -№ 5.-P. 117−26.
- Zahor Z., Czabanova V. Experimental atherosclerosis of the heart valves in rats following a long-term atherogenic regimen. //Atherosclerosis. 1977. — № 27. — P. 49−57.
- Zak F.G., Elias K. Embolization with material from atheromata. //Am. J. Med. Sci. 1949. -№ 218. — P. 510−515.
- Zapolski T., Wysokinski A., Przegalinski J. et al. Angina pectoris in patients with aortic valvular stenosis. //Pol. Arch. Med, Wewn. 2004. — № 112(4).-P. 1203−1210.
- Zezulka A., Mackinnon J., Beevers D.J. Hypertension in aortic valve disease and its response to valve replacement. //Postgrad. Med. J. 1992. — № 68.-P. 180−185.
- Zile M.R., Gasch W.H. Heart failure in aortic stenosis improving diagnosis and treatment. //N. Engl. J. Med. — 2003. — № 348. — P. 1735−1736.
- Zitterman A., Schleithoff S., Tenderich G. Et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure. //JACC. -2003.-41(1).-P. 105−112.